TITLE

Journal abstracts

PUB. DATE
May 1999
SOURCE
Palliative Medicine;1999, Vol. 13 Issue 3, p266
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the abstract of the study `Management of Sickle Cell Disease,' by M.H. Steinberg, published in a 1999 issue of the `New England Journal of Medicine.'
ACCESSION #
2003573

 

Related Articles

  • Contraception and sickle cell disease.  // American Family Physician;12/1/1994, Vol. 50 Issue 8, p1819 

    Cites the role of Depo-Provera in reducing the incidence of sickle cell crisis and improving red cell survival. Usefulness as a contraceptive in women with sickle cell disease of sickle cell trait; August 1994 issue of `The Practitioner' as source of information; Use of oral contraceptives as...

  • NEW ADVANCES IN THE TREATMENT OF SICKLE CELL DISEASE: FOCUS ON PERIOPERATIVE SIGNIFICANCE. Dix, Heidi M. // AANA Journal;Aug2001, Vol. 69 Issue 4, p281 

    Presents information on several medical advances in the treatment of sickle cell disease. Preoperative transfusion; Hydroxyurea; Purified poloxamer 188; Fructose 1-6 diphosphate; Nonopiate and epidural analgesia.

  • Hydroxyurea eases painful crises in sickle cell anemia.  // Modern Medicine;Oct95, Vol. 63 Issue 10, p51 

    Presents an abstract of the article `Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia,' by S. Charache, M.L. Terrin, R.D. Moore, et al from the `New England Journal of Medicine' dated June 22, 1995.

  • New drug treats common blood disease.  // Current Science;4/28/95, Vol. 80 Issue 17, p7 

    Informs the effectiveness of a drug, hydroxyurea in curing sickle-cell anemia. Symptoms and etiology of sickle-cell anemia; Effect of the drug; Results of experimental studies.

  • Hydroxyurea for management of painful sickle cell crises.  // American Family Physician;9/15/1995, Vol. 52 Issue 4, p1200 

    Reports on a study by Charache and colleagues published in the May 18, 1995 issue of the `New England Journal of Medicine' which determines whether treatment with hydroxyurea can reduce the frequency of painful crises in sickle cell anemia. Reduction in the number and severity of painful crises...

  • Phytochemical and Antisickling Studies of the Leaves of Hymenocardia acida Tul (Euphorbiaceae). Ibrahim, H.; Sani, F. S.; Danladi, B. H.; Ahmadu, A. A. // Pakistan Journal of Biological Sciences;2007, Vol. 10 Issue 5, p788 

    The leaves of Hymenocardia acida are commonly used in Northern Nigeria alone or in combination with other plant parts to manage sickle cell disease. Phytochemical screening and antisickling studies were carried out. The phytochemical screening revealed the presence of carbohydrates, tannins,...

  • Corticosteroid may cut sickle cell pain. Hurley, Mary Lou // RN;Jul94, Vol. 57 Issue 7, p78 

    Reports on the therapeutic effect of corticosteroids in reducing pain in patients with sickle cell anemia. Study findings; Pain rebound.

  • Injectable eases sickle-cell pain. Althaus, Frances // International Family Planning Perspectives;Jun98, Vol. 24 Issue 2, p54 

    Reports that contraceptives containing progestogen, particularly the injectable depot medroxy-progesterone (DMPA), may lower the frequency and intensity of pain related to sickle-cell anemia. Decrease in the proportion of women experiencing painful crisis in a study conducted in Panama;...

  • A sickle cell cure, but not for all.  // U.S. News & World Report;8/19/96, Vol. 121 Issue 7, p10 

    Focuses on sickle cell disease, long synonymous with an inherited, lifelong and incurable disorder. Report in the `New England Journal of Medicine' on use of bone-marrow transplants in combating disease; Drawbacks to the procedure.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics